Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab

J Rheumatol. 2007 Dec;34(12):2497-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging
  • Spondylitis, Ankylosing / diagnosis*
  • Spondylitis, Ankylosing / drug therapy*
  • Time Factors
  • Treatment Outcome
  • Whole Body Imaging*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab